✦ LIBER ✦

PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy

✍ Scribed by F. Morisco; D. Amoruso; T. Stroffolini; N. Caporaso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

78 The HCV NS3 protease inhibitor SCH 50

✍ S. Zeuzem; C. Sarrazin; F. Wagner; R. Rouzier; N. Forestier; S. Gupta; M. Hussai 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Re-treatment virologic response in chron

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

471 Long-term follow-up of previous HCV

✍ A. Ciancio; A. Olivero; A. Smedile; C. Colletta; G. Croce; L. Roffi; G. Cariti; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

338 A pilot trial of thymalfasin (Thymos

✍ Jorge L. Poo; Xochil Garcia; Eduardo B. Martins; David Kershanobich 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Virologic response in re-treatment of ch

✍ Pimstone, Neville R.; Canio, John B.; Powell, Jerry S.; Kokosinski, Janet; Saich 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Combining INF alfa 2b with PEG-INF alfa-

✍ Gioe, Scott M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB